{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T08:14:44Z","timestamp":1680423284560},"reference-count":23,"publisher":"Japanese Association of Virology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2009]]},"DOI":"10.2222\/jsv.59.249","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T06:07:15Z","timestamp":1278310035000},"page":"249-256","source":"Crossref","is-referenced-by-count":1,"title":["A live attenuated varicella vaccine"],"prefix":"10.2222","volume":"59","author":[{"given":"Yoshizo","family":"ASANO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1)Takahashi M, Otsuka T, Okuno T, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet ii: 1288-1290, 1974.","DOI":"10.1016\/S0140-6736(74)90144-5"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.22.11447-11459.2002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Gomi Y, Imagawa T, Takahashi M, Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J Med Virol 61: 497-503, 2000","DOI":"10.1002\/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4)Ozaki T, Nishimura N, Muto T, Sugata K, Kawabe S, Goto K, Koyama K, Fujita H, Takahashi Y, Akiyama M. Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan. Vaccine 23: 1205-1208, 2005","DOI":"10.1016\/j.vaccine.2004.08.040"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.606"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042271"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 294:797-802, 2005","DOI":"10.1001\/jama.294.7.797"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114:786-792, 2004","DOI":"10.1542\/peds.2004-0012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. J Pediatr 144:68-74, 2004","DOI":"10.1016\/j.jpeds.2003.10.025"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356:1121-1129, 2007","DOI":"10.1056\/NEJMoa064040"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Takayama N, Minamitani M, Takayama M. High incidence of breakthrough varicella in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain). Acta Paediatr Jap 39: 663-668, 1997","DOI":"10.1111\/j.1442-200X.1997.tb03664.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)Ozaki T, Nishimura N, Kajita Y. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic. Vaccine 18: 2375-2380, 2000","DOI":"10.1016\/S0264-410X(00)00016-5"},{"key":"13","unstructured":"13)Vessey SJR, Chan CY, Kuter BJ, Kaplan KM, Waters M, Kutzler DP, Carfagno PA, Sadoff JC, Heyse JF, Mattebews H, Li S, Chan IS. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy. J Pediatr 139: 297-304, 2001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14)Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, The study group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23: 132-137, 2004","DOI":"10.1097\/01.inf.0000109287.97518.67"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Seward JF, Zhang JX, Maupin T, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases-a household contact study. JAMA 292: 704-708, 2004","DOI":"10.1001\/jama.292.6.704"},{"key":"16","unstructured":"16)Haddad MB, Hill MB, Pavia AT Green CE, Jumaan AO, De AK, Rolfs RT. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics 115: 1488-1493, 2005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Asano Y, Itakura N, Hiroishi Y, Hirose S, Ozaki T, Kuno K, Nagai T, Yazaki T, Yamanishi K, Takahashi M. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 152:863-868, 1985.","DOI":"10.1093\/infdis\/152.5.863"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325:1545-1550, 1991","DOI":"10.1056\/NEJM199111283252204"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Wood SM, Shah SS, Steenhoff AP, Rutstein RM. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics 121:e150-e156, 2008","DOI":"10.1542\/peds.2007-0564"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20)Takahashi M, Okada S, Miyagawa H, Amo K, Yoshikawa K, Asada H, Kamiya H, Torigoe S, Asano Y, Ozaki T, Terada K, Muraki R, Higa K, Iwasaki H, Akiyama M, Takamizawa A, Shiraki K, Yanagi K, Yamanishi K. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 21:3845-3853, 2003","DOI":"10.1016\/S0264-410X(03)00303-7"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"22","unstructured":"22)Harpaz R, Ortega-Sanchez IR, Seward JF: Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR 57: 1-30, 2008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23)Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators. Varicella-zoster virus - specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 197: 825-835, 2008","DOI":"10.1086\/528696"}],"container-title":["Uirusu"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:40:52Z","timestamp":1621532452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsv\/59\/2\/59_2_249\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.59.249","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}